NXL
NEXALIN TECH (NXL)
NASDAQ
$0.37-$0.007 (-1.91%)
Price as of Jun 23, 2026 7:58 PM EDT
  • $8.0M
    Market Cap
  • -64.56%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
301,647
+78.78%
168,721
+52.35%
110,748
-91.62%
1.3M
N/A
Cost of Revenue
61,373
+67.72%
36,593
+42.45%
25,688
-92.93%
363,212
N/A
Gross Profit
240,274
+81.85%
132,128
+55.34%
85,060
-91.12%
958,145
N/A
Sales and Marketing Expense
4.4M
+4.00%
4.2M
+10.74%
3.8M
+156.00%
1.5M
N/A
Research and Development Expense
-1.1M
-9.02%
-1.2M
-38.04%
-1.9M
-476.13%
511,000
N/A
Depreciation and Amortization Expense
21,537
+42.56%
15,107
+2,903.38%
503
-5.98%
535
N/A
Total Operating Expenses
8.6M
+9.44%
7.9M
+36.42%
5.8M
+107.13%
2.8M
N/A
Operating Profit
-8.4M
+8.20%
-7.8M
+36.13%
-5.7M
+210.76%
-1.8M
N/A
Interest Income
161,508
+15.84%
139,420
N/A
N/A
N/A
N/A
N/A
Interest Expense
-8,240
+158.06%
-3,193
-91.78%
-38,835
-34.60%
-59,382
N/A
Interest Income and Expense and Net
153,268
+12.51%
136,227
+450.78%
-38,835
-165.40%
59,382
N/A
Total Nonoperating Income and Expense
169,748
+19.03%
142,613
-86.39%
1.0M
+674.76%
135,215
N/A
Income before Taxes
-8.2M
+8.00%
-7.6M
+33.63%
-5.7M
+210.76%
-1.8M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-8.2M
+8.07%
-7.6M
+63.64%
-4.6M
+173.81%
-1.7M
N/A
Net Income from Continuing Operations Applicable to Common
-8.2M
+8.00%
-7.6M
+63.75%
-4.6M
+173.81%
-1.7M
N/A
Basic EPS and Net Income
-0.50
-39.76%
-0.83
+31.75%
-0.63
N/A
N/A
N/A
Diluted EPS and Net Income
-0.50
-39.76%
-0.83
+31.75%
-0.63
N/A
N/A
N/A
Basic Weighted Average Shares
16.4M
+77.87%
9.2M
+25.26%
7.4M
N/A
N/A
N/A
Diluted Weighted Average Shares
16.4M
+77.87%
9.2M
+25.26%
7.4M
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
654,783
+13.98%
574,485
-0.99%
580,230
+256.53%
162,743
N/A
Short-Term Investments
3.1M
+5.61%
2.9M
+22.69%
2.4M
-65.33%
6.8M
N/A
Cash and Cash Equivalents and Short-Term Investments
3.7M
+6.99%
3.5M
+18.03%
2.9M
-57.84%
7.0M
N/A
Total Current Assets
4.3M
+8.54%
4.0M
+15.49%
3.4M
-53.81%
7.4M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
2,684
+23.06%
2,181
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
503
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
503
N/A
Total Assets
4.6M
+9.77%
4.2M
+16.27%
3.6M
-51.13%
7.4M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
500,000
N/A
Total Current Liabilities
887,333
+62.31%
546,694
+28.55%
425,281
-78.18%
1.9M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
22,916
-91.90%
282,916
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
4,463
0.00%
4,463
N/A
Total Liabilities
887,333
+62.31%
546,694
+28.55%
425,281
-78.23%
2.0M
N/A
Retained Earnings
-92.9M
+9.71%
-84.6M
+9.87%
-77.0M
+6.42%
-72.4M
N/A
Total Stockholders Equity
3.7M
+1.96%
3.7M
+14.64%
3.2M
-41.47%
5.5M
N/A
Total Shares Outstanding
19.2M
+44.22%
13.3M
+78.89%
7.4M
+2.06%
7.3M
N/A
Cash Flow
Cash from Operating Activities
-5.0M
+25.69%
-3.9M
+2.84%
-3.8M
+73.10%
-2.2M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-131,991
-77.15%
-577,539
-112.97%
4.5M
+165.53%
-6.8M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
5.2M
+14.48%
4.5M
+2,358.09%
-200,000
-102.35%
8.5M
N/A
Financials Ratio
Gross Margin
79.65%
+1.71%
78.31%
+1.96%
76.81%
N/A
N/A
N/A
Operating Margin
-2,781.69%
-39.48%
-4,596.14%
-10.64%
-5,143.48%
N/A
N/A
N/A
Return on Assets
-185.62%
-4.17%
-193.70%
+130.51%
-84.03%
N/A
N/A
N/A
Return on Equity
-221.48%
+0.19%
-221.06%
+106.50%
-107.05%
N/A
N/A
N/A
Revenue Growth
78.78%
+50.50%
52.35%
+157.14%
-91.62%
N/A
N/A
N/A
Current Ratio
4.85
-33.13%
7.25
-10.16%
8.07
N/A
N/A
N/A
Cash Ratio
0.74
-29.78%
1.05
-22.98%
1.36
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow